Merit Medical Systems (MMSI) Cost of Revenue (2010 - 2026)

Merit Medical Systems' Cost of Revenue history runs 17 years deep, the most recent figure standing at $197.1 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 7.5% year-over-year to $197.1 million; the TTM figure through Mar 2026 stood at $791.4 million (up 9.2% YoY), while the FY2025 annual figure was $777.6 million, up 9.04% from the prior year.
• Cost of Revenue came in at $197.1 million for Q1 2026 at Merit Medical Systems, down from $198.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $198.6 million in Q4 2025 to a low of $154.5 million in Q1 2022.
• A 5-year average of $176.1 million and a median of $174.0 million in 2023 frame the typical range for Cost of Revenue.
• On a YoY basis, Cost of Revenue climbed as much as 12.76% in 2022 and fell as far as 2.38% in 2022.
• Merit Medical Systems' Cost of Revenue stood at $158.9 million in 2022, then rose by 9.52% to $174.0 million in 2023, then gained by 4.71% to $182.2 million in 2024, then gained by 9.01% to $198.6 million in 2025, then dropped by 0.76% to $197.1 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $197.1 million, $198.6 million, and $197.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison